companydata.dkReshape ApS: Financial statements 2024
CVR: 40056173
Reshape ApS (CVR 40056173) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,728,927 and a net result of DKK -12,222,020 compared with DKK -4,638,554 the year before. That is a decrease of 12.2% compared with the year before. Equity amounted to DKK 25,058,134. The solvency ratio was 87.5%. The company had 18 employees in the financial year.
- Gross Profit
- 1,728,927 kr.
- Profit/Loss
- -12,222,020 kr.
- Equity
- 25,058,134 kr.
- Total Assets
- 28,631,868 kr.
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.7 mio. | -12.2 mio. | 25.1 mio. | 18 |
| 2023 | - | 2 mio. | -4.6 mio. | 26.9 mio. | 10 |
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
| 2021 | - | 593 t. | 52 t. | 1.3 mio. | 7 |
How creditworthy is Reshape ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Magnus Nyborg Madsen, Daniel Storgaard and Carl-Emil Grøn Fuglesang. The company is owned by Reshape Biotech Inc.. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity amounted to DKK 75,515,117.